anti-INFLUENZA B NUCLEOPROTEIN antibody product blog
Tags: Antibody; Monoclonal Antibody; INFLUENZA B NUCLEOPROTEIN; anti-INFLUENZA B NUCLEOPROTEIN antibody;
The INFLUENZA B NUCLEOPROTEIN n/a (Catalog #MBS213001) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s INFLUENZA B NUCLEOPROTEIN can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Western Blot (WB). Researchers should empirically determine the suitability of the INFLUENZA B NUCLEOPROTEIN n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MBS213001 specifically recognises an epitope within the nucleoprotein of influenza B virus. The influenza viruses, classified as type A, B and C, are members of the Orthomyxoviridae family which differ in their epidemiology and host ranges and lack serological cross-reactivity of their internal components, especially their matrix proteins and nucleoprotein. Influenza B virus is a slow-mutating single stranded RNA virus subject to antigenic drift which, although enough to prevent lasting immunity, prevents influenza B from causing pandemics. MBS213001 can be used in influenza B IFA typing in conjunction with MBS214479 (clone B114).
Perservative Stabilisers: 0.09% Sodium Azide
Preparation: Purified IgG prepared by affinity chromatography from tissue culture supernatant. Immunogen: Influenza B/Lee/40 and B/Singapore/-222/79 viruses.
Fusion Partners: Spleen cells from immunised BALB/c mice were fused with cells of the P3 Ag8.653 mouse myeloma cell line.
Buffer Solution: Phosphate buffered saline
Target Species: Viral. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing INFLUENZA B NUCLEOPROTEIN are readily searchable from our website. Different antibodies against the same target such as INFLUENZA B NUCLEOPROTEIN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.